赵贝,等.微小RNA与胰腺癌化疗耐药的研究进展 2019年第40卷第1期 综述评论 35] Ji Q, Hao X, Zhang M, et al. MicroRNA miR-34 K-Ras oncogenic nd promotes ROS stress in pancreatic human pancreatic cancer tumor-initiating cells [J].Pl cancer. Oncotarget,2015,6(25):21148-21158 2009,4(8):c6816-c6816 146] Taucher V, Mangge H, Haybaeck J Non-coding RNAs in 36] Zhang Q, Yang X, Chen D, et al. miR-34 increases in vitro pancreatic cancer: challenges and opportunities for clinical PANC-I cell sensitivity to gemcitabine via targeting Slug application [J]. Cellr Oncol l (Dordr), 2016, 39(4): 295-318 PUMA[]. Cancer Biomark, 2018. 21(4): 755-762 [47 Richards KE. Zeleniak AE Fishel ML, et al. Cancer-associated 37] Humphries B, Yang C. The microRNA-200 family: small fibroblast exosomes regulate survival and proliferation molecules with novel roles in cancer development, progression of pancreatic cancer cells[J]. Oncogene, 2017, 36(13) and therapy [J1. Oncotarget, 2015, 6(9): 6472-6498 1770-1778 38] Zhou J, Zhang L, Zhang T, et al. Dysregulation of miR-200s [48] er R, Mezencev R, Matyunina Lv, et al. Evidence for clusters as potential prognostic biomarkers in acute myeloid the role of microRNA 374b in acquired cisplatin resistance in 67 leukemia[j]. J Transl Med, 2018. 16(1): 135-13s pancreatic cancer cells[J]. Cancer Gene Ther, 2016, 23(8 39] San K, Horita M, Ganapathy A, et al. Deregulated expression 241-245 of microRNA-200b/c and SUZI2, a polycomb repressive [49] Lin Y, Ge X, Wen Y, et al. MiRNA-145 increases therapeutic A complex 2 subunit, in chemoresistant colorectal cancer sensibility to gemcitabine treatment of pancreatic 3 ls[J]. Genes Cancer,2017,8(7-8):673-673 adenocarcinoma cells[J]. Oncotarget, 2016, 7(43) [40] Mekala JR, Naushad SM, Ponnusamy L, et al. Epigenetic 70857-70857. regulation of miR-200 as the potential strategy for the therapy [50] Cioffi M, Trabulo SM, Sanchez-Ripoll Y, et al. The miR-17-92 against triple-negative breast cancer[Jl. Gene, 2018, 641 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells[J]. Gut, 41] Dykxhoorn DM. MicroRNAs and metastasis: little rmas go a 015,64(12):1936-1948 long way [J]. Cancer Res, 2010, 70(16): 6401-6406 [51] Takiuchi D, Eguchi H, Nagano H, et al. Involvement of 42] Ma C, Huang T, ding y C, et al. MicroRNA-200c microRNA-18lb in the gemcitabine resistance of pancreatic overexpression inhibits chemoresistance, invasion and colony cancer cells [J]. Pancreatology, 2013, 13(5): 517-523 formation of human pancreatic cancer stem cells[J]. Int J Clin 52] Chen M, Wang M, Xu S, et al. Upregulation of miR-181c Exp Pathol,2015,8(6):6533-6539 ontributes to chemoresistance in pancreatic cancer by 43] Singh S, Chitkara D, Kumar V, et al. miRNA profiling in inactivating the Hippo signaling pathway [J]. Oncotarget, pancreatic cancer and restoration of chemosensitivity [J 015,6(42):44466-44479 Cancer lett,2013,34(2):211-220 [53] Hasegawa S, Eguchi H, Nagano H, et al. MicroRNA-1246 44] Chaudhary AK, Mondal G, Kumar V, et al. Chemosensitization expression associated with CCNG2-mediated chemoresistance and inhibition of pancreatic cancer stem cell proliferation by and stemness in pancreatic cancer [J]. Br J Cancer, 2014 overexpression of microRNA-205 []. Cancer Lett, 2017, 402 lll(8):1572-1580. (责任编辑:赵绪韬) 45] Wang P, Zhu CF, Ma MZ, et al. Micro-RNA-155 is induced by672019 Vol.40 No.1 2019 年第 40 卷第 1 期 67 综述评论 [35] Ji Q, Hao X, Zhang M, et al. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells[J]. PLoS One, 2009, 4(8): e6816-e6816. [36] Zhang Q, Yang X, Chen D, et al. miR-34 increases in vitro PANC-1 cell sensitivity to gemcitabine via targeting Slug/ PUMA[J]. Cancer Biomark, 2018, 21(4): 755-762. [37] Humphries B, Yang C. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy[J]. Oncotarget, 2015, 6(9): 6472-6498. [38] Zhou J, Zhang L, Zhang T, et al. Dysregulation of miR-200s clusters as potential prognostic biomarkers in acute myeloid leukemia[J]. J Transl Med, 2018, 16(1): 135-135. [39] San K, Horita M, Ganapathy A, et al. Deregulated expression of microRNA-200b/c and SUZ12, a polycomb repressive complex 2 subunit, in chemoresistant colorectal cancer cells[J]. Genes Cancer, 2017, 8(7-8): 673-673. [40] Mekala JR, Naushad SM, Ponnusamy L, et al. Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer[J]. Gene, 2018, 641: 248-258. [41] Dykxhoorn DM. MicroRNAs and metastasis: little rnas go a long way[J]. Cancer Res, 2010, 70(16): 6401-6406. [42] Ma C, Huang T, Ding Y C, et al. MicroRNA-200c overexpression inhibits chemoresistance, invasion and colony formation of human pancreatic cancer stem cells[J]. Int J Clin Exp Pathol, 2015, 8(6): 6533-6539. [43] Singh S, Chitkara D, Kumar V, et al. miRNA profiling in pancreatic cancer and restoration of chemosensitivity[J]. Cancer Lett, 2013, 334(2): 211-220. [44] Chaudhary AK, Mondal G, Kumar V, et al. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205[J]. Cancer Lett, 2017, 402: 1-8. [45] Wang P, Zhu CF, Ma MZ, et al. Micro-RNA-155 is induced by K-Ras oncogenic signal and promotes ROS stress in pancreatic cancer[J]. Oncotarget, 2015, 6(25): 21148-21158. [46] Taucher V, Mangge H, Haybaeck J. Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application[J]. Cellr Oncol l(Dordr) , 2016, 39(4): 295-318. [47] Richards KE, Zeleniak AE, Fishel ML, et al. Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells[J]. Oncogene, 2017, 36(13): 1770-1778. [48] Schreiber R, Mezencev R, Matyunina LV, et al. Evidence for the role of microRNA 374b in acquired cisplatin resistance in pancreatic cancer cells[J]. Cancer Gene Ther, 2016, 23(8): 241-245. [49] Lin Y, Ge X, Wen Y, et al. MiRNA-145 increases therapeutic sensibility to gemcitabine treatment of pancreatic adenocarcinoma cells[J]. Oncotarget, 2016, 7(43): 70857-70857. [50] Cioffi M, Trabulo SM, Sanchez-Ripoll Y, et al. The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells[J]. Gut, 2015, 64(12): 1936-1948. [51] Takiuchi D, Eguchi H, Nagano H, et al. Involvement of microRNA-181b in the gemcitabine resistance of pancreatic cancer cells[J]. Pancreatology, 2013, 13(5): 517-523. [52] Chen M, Wang M, Xu S, et al. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway[J]. Oncotarget, 2015, 6(42): 44466-44479. [53] Hasegawa S, Eguchi H, Nagano H, et al. MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer[J]. Br J Cancer, 2014, 111(8): 1572-1580. (责任编辑：赵绪韬) 赵 贝 , 等 . 微小 RNA 与胰腺癌化疗耐药的研究进展